The revised guidelines now take into account new developments and relevant advances in knowledge, such as the ongoing debate about safety related to intravenous gadolinium-based contrast agents. The value of spinal cord MRI for diagnostic, prognostic, and surveillance purposes has been re-evaluated. Standardization of brain and spinal cord MRI protocols for diagnosis, assessment of prognosis, and monitoring of therapy, as well as the use of 3D-FLAIR (three-dimensional fluid-attenuated inversion recovery) as the most important sequence in the diagnosis of lesions in the brain have been included, as this allows better interpretation and comparability, e.g., in follow-up assessments.
Keyphrases
- contrast enhanced
- spinal cord
- magnetic resonance imaging
- multiple sclerosis
- magnetic resonance
- white matter
- diffusion weighted imaging
- computed tomography
- resting state
- spinal cord injury
- neuropathic pain
- healthcare
- clinical practice
- public health
- high dose
- functional connectivity
- stem cells
- bone marrow
- clinical evaluation
- mesenchymal stem cells
- cell therapy